Optimization of a therapeutic electromagnetic field (EMF) to retard breast cancer tumor growth and vascularity.

Cameron, Ivan L; Markov, Marko S; Hardman, W Elaine

Cameron, Ivan L; Markov, Marko S; Hardman, W Elaine.

Affiliation

Cameron IL; Department of Cellular and Structural Biology, University of Texas Health Science at San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas 78229 USA.
Markov MS; Research International, Williamsville, New York 14221 USA.
Hardman WE; Department of Biochemistry and Microbiology, Joan C. Edwards School of Medicine, Marshall University, 1600 Medical Center Dr., Huntington, 25755 West Virginia.

Cancer Cell Int ; 14(1): 125, 2014.

Article in En | MEDLINE | ID: mdl-25530714

Key words

Angiogenesis; Breast cancer; Electromagnetic field (EMF); Endothelial cell marker (CD31); Immunohistochemical

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Cell Int Year: 2014 Type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Cell Int Year: 2014 Type: Article